Cancer immunotherapies that boost the immune system’s response, such as Opdivo (nivolumab), may increase risk for autoimmune disorders, including myasthenia…
Researchers in Taiwan have found that first-degree relatives of individuals with myasthenia gravis have a higher risk of developing the disease.
Researchers have found that the drug ONX-0914 halts disease progression in an animal model of myasthenia gravis by altering…
Catalyst Pharmaceuticals announced that it will soon begin a Phase 3 clinical trial to assess Firdapse (amifampridine phosphate) in people…
Muscle regeneration in myasthenia gravis likely is delayed as a result of the impaired functioning of…
Get regular updates to your inbox.
